BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

872 related articles for article (PubMed ID: 27677286)

  • 1. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
    Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
    Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells.
    Ding ZY; Liu GH; Olsson B; Sun XF
    Tumour Biol; 2013 Apr; 34(2):683-93. PubMed ID: 23188704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells].
    Liu P; Wang TS; You SH; Ge HM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
    Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
    Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Co-transfection with Livin and survivin shRNA expression vectors on biological behavior of HepG2 cells.
    Xu W; Chang H; Qin CK; Zhai YP
    Asian Pac J Cancer Prev; 2013; 14(9):5467-72. PubMed ID: 24175843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated.
    Yin L; Liu S; Li C; Ding S; Bi D; Niu Z; Han L; Li W; Gao D; Liu Z; Lu J
    Tumour Biol; 2016 Sep; 37(9):12731-12742. PubMed ID: 27448305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-mediated miR-214 regulates proliferation and drug sensitivity of renal cell carcinoma cells through targeting LIVIN.
    Xu H; Wu S; Shen X; Shi Z; Wu D; Yuan Y; Jiang W; Wang Q; Ke Q; Mao Q; Li X; Liu Y; Yuan P; Zhang Q; Huang E; Chen X
    J Cell Mol Med; 2020 Jun; 24(11):6410-6425. PubMed ID: 32395888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligonucleotide targeting Livin induces apoptosis of human bladder cancer cell via a mechanism involving caspase 3.
    Liu C; Wu X; Luo C; Hu Z; Yin Z; He Y; Du H; Zhang W; Jiang Q; Lin Y
    J Exp Clin Cancer Res; 2010 Jun; 29(1):63. PubMed ID: 20525250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. siRNA directed against Livin inhibits tumor growth and induces apoptosis in human glioma cells.
    Yuan B; Ran B; Wang S; Liu Z; Zheng Z; Chen H
    J Neurooncol; 2012 Mar; 107(1):81-7. PubMed ID: 22086237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of non‑small cell lung cancer cells.
    Huang Q; Zeng Y; Lin H; Zhang H; Yang D
    Mol Med Rep; 2017 Nov; 16(5):7086-7091. PubMed ID: 28901499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CCAT1 inhibits cell apoptosis of renal cell carcinoma through up-regulation of Livin protein.
    Chen S; Ma P; Li B; Zhu D; Chen X; Xiang Y; Wang T; Ren X; Liu C; Jin X
    Mol Cell Biochem; 2017 Oct; 434(1-2):135-142. PubMed ID: 28470345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. siRNA targeting Livin decreases tumor in a xenograft model for colon cancer.
    Oh BY; Lee RA; Kim KH
    World J Gastroenterol; 2011 May; 17(20):2563-71. PubMed ID: 21633662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis.
    Crnković-Mertens I; Wagener N; Semzow J; Gröne EF; Haferkamp A; Hohenfellner M; Butz K; Hoppe-Seyler F
    Cell Mol Life Sci; 2007 May; 64(9):1137-44. PubMed ID: 17437058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma.
    Liu X; Wang A; Gao H; Yuan Z; Jiao Y
    Int J Oncol; 2012 Sep; 41(3):1021-8. PubMed ID: 22766624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the apoptosis inhibitor livin in renal cell carcinomas: correlations with pathology and outcome.
    Kempkensteffen C; Hinz S; Christoph F; Krause H; Koellermann J; Magheli A; Schrader M; Schostak M; Miller K; Weikert S
    Tumour Biol; 2007; 28(3):132-8. PubMed ID: 17519534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney.
    Wagener N; Crnković-Mertens I; Vetter C; Macher-Göppinger S; Bedke J; Gröne EF; Zentgraf H; Pritsch M; Hoppe-Seyler K; Buse S; Haferkamp A; Autschbach F; Hohenfellner M; Hoppe-Seyler F
    Br J Cancer; 2007 Nov; 97(9):1271-6. PubMed ID: 17968430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Livin gene RNA interference on apoptosis of cervical cancer HeLa cells and enhanced sensitivity to cisplatin.
    Yu L; Wang Z
    J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):625-30. PubMed ID: 19821098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. URGCP/URG4 promotes apoptotic resistance in bladder cancer cells by activating NF-κB signaling.
    Wu M; Chen J; Wang Y; Hu J; Liu C; Feng C; Zeng X
    Oncotarget; 2015 Oct; 6(31):30887-901. PubMed ID: 26429874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.